Bladder Cancer Clinical Trials

A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

UPDATED

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Non-muscle Invasive Bladder Cancer

Birmingham Alabama 35294

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Birmingham Alabama 35294

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

Arizona

Phoenix Arizona 85032

A clinical trial to evaluate treatments using CG0070 for patients with Bladder Cancer

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tucson Arizona 85724

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Arkansas

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

California

Mirati Research Site
Duarte California 91010

Phase 2 Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes

View More ▼

UPDATED

Fullerton California 92835

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

UPDATED

La Jolla California 92093

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

UPDATED

Redondo Beach California 90277

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

UPDATED

Sacramento California 95817

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

UPDATED

San Francisco California 94158

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

UPDATED

Santa Monica California 93454

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Duarte California 91010-3000

A clinical research study of BGJ398 for the treatment of Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication, or Advanced Solid Tumors With FGFR3 Mutation

Duarte California 91010

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

La Jolla California 92093-0658

A clinical research study of BGJ398 for the treatment of Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication, or Advanced Solid Tumors With FGFR3 Mutation

Lancaster California 93534

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Los Angeles California 90024

A clinical research study of [124I] PSCA-Minibody PET/CT imaging of the whole body for the treatment of Prostate Cancer, Pancreatic Cancer or Bladder Cancer

Los Angeles California 90033

A clinical research study of BGJ398 for the treatment of Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication, or Advanced Solid Tumors With FGFR3 Mutation

Los Angeles California 90095

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

Los Angeles California 90095

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles California 90095

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Los Angeles California 90095

Patients are needed to participate in a clinical research study of CM-24

Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Bladder Cancer

Sacramento California 95817

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

San Francisco California 94158

Patients are needed to participate in a clinical research study of Pembrolizumab (MK-3475) to evaluate Urothelial Cancer (MK-3475-052/KEYNOTE-52)

Sherman Oaks California 91411

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

Stanford California 94305

A clinical trial seeking patients for a research study of Pazopanib (GW786034) and Paclitaxel

Torrance California 90505

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

Colorado

The Urology Center of Colorado
Denver Colorado 80211

A Phase 1/2a, placebo controlled, randomized study to evaluate the safety, immune response and clinical activity of HS-410 in patients with high risk superficial bladder cancer who have undergone Transurethral Resection of Bladder (TURBT) and received prior treatment with induction of Bacillus Calmette-Guerin (BCG).

View More ▼

UPDATED

Grand Junction Colorado 81501

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132

Denver Colorado 80211

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

Connecticut

UPDATED

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

New Haven Connecticut 06520

A clinical research study of BGJ398 for the treatment of Advanced Solid Tumors With FGFR1 Amplication,, Advanced Solid Tumors With FGFR2 Amplication, or Advanced Solid Tumors With FGFR3 Mutation

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of CM-24

Delaware

Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington District of Columbia 20057

A clinical trial to evaluate treatments using Chemotherapy and MPDL3280A for patients with Bladder Cancer

Florida

Mirati Research Site
Fort Myers Florida 33905

Phase 2 Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes

View More ▼

UPDATED

Fort Myers Florida 33916-2233

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

UPDATED

Gainesville Florida 32610

Patients are needed to participate in a clinical research study of pembrolizumab, paclitaxel, vinflunine and docetaxel to evaluate Urothelial Cancer

UPDATED

St. Petersburg Florida 33705

Patients are needed to participate in a clinical research study of Ramucirumab (LY3009806), Docetaxel and Placebo to evaluate Urothelial Carcinoma

Orlando Florida 32806

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis